International
aetherAI Machine Learning Approach for Classification of Primary Intestinal T-Cell Lymphomas Published in Cancers TAIPEI, TAIWAN, April 6, 2022 /EINPresswire.com/ -- aetherAI—Asia’s leading medical image AI solution provider focused on...
Join Deep Bio at AACR 2022! At this year’s AACR, Deep Bio will present both on-site and virtually! Visit us at booth #1461 to share your thoughts on the role of digital pathology and AI in cancer research. Also, don’t forget to see the...
PARIS, France and CAMBRIDGE, Mass. – Keen Eye, a leading AI company in digital pathology for clinical research and Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies,...
March 21, 2022: Today, Visiopharm launches Qualitopix™ for AI-driven standardization of tissue staining at USCAP 2022 is introducing its novel and unique Qualitopix™ solution to delegates at the United States and Canadian Academy of...
Led by Section 32 and Sanofi Ventures, funding will enable Nucleai to expand its commercial footprint in biopharma and further develop its state-of-the-art spatial biology platform TEL AVIV, Israel--(BUSINESS WIRE)--Nucleai, an AI-powered...
Proscia and Visiopharm: Partnership to improve clinical decision making for breast and colon cancer care HOERSHOLM, Denmark & PHILADELPHIA – March 22, 2022 – Proscia®, a leader in digital and computational pathology solutions, and...
